[
  {
    "ts": null,
    "headline": "AbbVie (ABBV) Stock Sinks As Market Gains: Here's Why",
    "summary": "The latest trading day saw AbbVie (ABBV) settling at $209.17, representing a -0.4% change from its previous close.",
    "url": "https://finnhub.io/api/news?id=342ba6951d3f225a8b699d5ac96613736698b1c06392ab8ae2625aa0b6430225",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742852714,
      "headline": "AbbVie (ABBV) Stock Sinks As Market Gains: Here's Why",
      "id": 133360361,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "The latest trading day saw AbbVie (ABBV) settling at $209.17, representing a -0.4% change from its previous close.",
      "url": "https://finnhub.io/api/news?id=342ba6951d3f225a8b699d5ac96613736698b1c06392ab8ae2625aa0b6430225"
    }
  },
  {
    "ts": null,
    "headline": "Abbvie CEO Robert A. Michael's 2024 Total Compensation Was $18.5 Million - Filing",
    "summary": "Abbvie Inc: * ABBVIE: CEO ROBERT A. MICHAEL'S 2024 TOTAL COMPENSATIONWAS$18.5 MILLION - FILING * ABBVIE: EXECUTIVE CHAIRMAN RICHARD A. GONZALEZ'S 2024TOTALCOMPENSATION...",
    "url": "https://finnhub.io/api/news?id=3a54c853fd45cae9ed35c85944ce47a4a3b64f8a5e6aae71b74d51357c7d7ceb",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742834647,
      "headline": "Abbvie CEO Robert A. Michael's 2024 Total Compensation Was $18.5 Million - Filing",
      "id": 133358180,
      "image": "",
      "related": "ABBV",
      "source": "Finnhub",
      "summary": "Abbvie Inc: * ABBVIE: CEO ROBERT A. MICHAEL'S 2024 TOTAL COMPENSATIONWAS$18.5 MILLION - FILING * ABBVIE: EXECUTIVE CHAIRMAN RICHARD A. GONZALEZ'S 2024TOTALCOMPENSATION...",
      "url": "https://finnhub.io/api/news?id=3a54c853fd45cae9ed35c85944ce47a4a3b64f8a5e6aae71b74d51357c7d7ceb"
    }
  },
  {
    "ts": null,
    "headline": "Q4 Rundown: Moderna (NASDAQ:MRNA) Vs Other Therapeutics Stocks",
    "summary": "Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Moderna (NASDAQ:MRNA) and the best and worst performers in the therapeutics industry.",
    "url": "https://finnhub.io/api/news?id=bd1bb2332645bd43ba7bdf3c866c27086431f85b17a09a3641424158140bcc55",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742806869,
      "headline": "Q4 Rundown: Moderna (NASDAQ:MRNA) Vs Other Therapeutics Stocks",
      "id": 133337822,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Moderna (NASDAQ:MRNA) and the best and worst performers in the therapeutics industry.",
      "url": "https://finnhub.io/api/news?id=bd1bb2332645bd43ba7bdf3c866c27086431f85b17a09a3641424158140bcc55"
    }
  },
  {
    "ts": null,
    "headline": "Allergan Aesthetics Emphasizes Commitment to Innovation, Science and a Patient Centric Approach at AMWC 2025",
    "summary": "Allergan Aesthetics, an AbbVie company, the industry leader in aesthetics globally, demonstrates how to elevate the patient experience and achieve optimal treatment outcomes with new AA Signature program at the Anti-Aging and Aesthetics Medicine World Congress (AMWC) in Monaco from Thursday, March 27– Saturday, March 29, 2025.",
    "url": "https://finnhub.io/api/news?id=2ebf3ec49e7a8910aa5d91f7c9e7124be165f2244b625a154ba7e18c7588f4d7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742803320,
      "headline": "Allergan Aesthetics Emphasizes Commitment to Innovation, Science and a Patient Centric Approach at AMWC 2025",
      "id": 133337823,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Allergan Aesthetics, an AbbVie company, the industry leader in aesthetics globally, demonstrates how to elevate the patient experience and achieve optimal treatment outcomes with new AA Signature program at the Anti-Aging and Aesthetics Medicine World Congress (AMWC) in Monaco from Thursday, March 27– Saturday, March 29, 2025.",
      "url": "https://finnhub.io/api/news?id=2ebf3ec49e7a8910aa5d91f7c9e7124be165f2244b625a154ba7e18c7588f4d7"
    }
  },
  {
    "ts": null,
    "headline": "Genmab to Vigorously Defend Alleged Claims of Trade Secret Misappropriation by AbbVie Inc.",
    "summary": "COPENHAGEN, Denmark - Genmab A/S announced today that AbbVie Inc. has filed a complaint in the U.S. District Court for the Western District of Washington naming Genmab A/S; ProfoundBio US Co.;...",
    "url": "https://finnhub.io/api/news?id=eca3c0b229a78e9bfb75e5f55e02e77a57025518052df9f6c866fc1f40240f6e",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742794403,
      "headline": "Genmab to Vigorously Defend Alleged Claims of Trade Secret Misappropriation by AbbVie Inc.",
      "id": 133335636,
      "image": "",
      "related": "ABBV",
      "source": "Finnhub",
      "summary": "COPENHAGEN, Denmark - Genmab A/S announced today that AbbVie Inc. has filed a complaint in the U.S. District Court for the Western District of Washington naming Genmab A/S; ProfoundBio US Co.;...",
      "url": "https://finnhub.io/api/news?id=eca3c0b229a78e9bfb75e5f55e02e77a57025518052df9f6c866fc1f40240f6e"
    }
  }
]